Walgreens Boots Alliance, Inc. (NASDAQ:WBA) is Solas Capital Management LLC's 6th Largest Position

Solas Capital Management LLC reduced its holdings in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) by 13.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,116,787 shares of the pharmacy operator's stock after selling 167,767 shares during the quarter. Walgreens Boots Alliance accounts for about 6.9% of Solas Capital Management LLC's investment portfolio, making the stock its 6th largest holding. Solas Capital Management LLC owned about 0.13% of Walgreens Boots Alliance worth $10,420,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also recently added to or reduced their stakes in the stock. Coldstream Capital Management Inc. grew its position in shares of Walgreens Boots Alliance by 38.2% during the 4th quarter. Coldstream Capital Management Inc. now owns 44,459 shares of the pharmacy operator's stock valued at $415,000 after buying an additional 12,300 shares during the last quarter. Pingora Partners LLC lifted its holdings in Walgreens Boots Alliance by 69.9% in the fourth quarter. Pingora Partners LLC now owns 205,880 shares of the pharmacy operator's stock worth $1,921,000 after purchasing an additional 84,672 shares during the period. Syon Capital LLC increased its stake in Walgreens Boots Alliance by 96.0% during the 4th quarter. Syon Capital LLC now owns 24,753 shares of the pharmacy operator's stock valued at $231,000 after buying an additional 12,127 shares during the period. MGO One Seven LLC bought a new stake in Walgreens Boots Alliance during the fourth quarter worth approximately $231,000. Finally, Price T Rowe Associates Inc. MD raised its stake in shares of Walgreens Boots Alliance by 2.1% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 1,040,785 shares of the pharmacy operator's stock worth $9,712,000 after buying an additional 21,533 shares in the last quarter. 58.59% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

WBA has been the topic of several recent research reports. StockNews.com started coverage on shares of Walgreens Boots Alliance in a research report on Saturday, April 19th. They issued a "hold" rating on the stock. Bank of America boosted their price objective on shares of Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an "underperform" rating in a research report on Monday, January 13th. Royal Bank of Canada boosted their target price on Walgreens Boots Alliance from $9.00 to $12.00 and gave the company a "sector perform" rating in a research note on Wednesday, January 15th. Truist Financial dropped their price target on shares of Walgreens Boots Alliance from $13.00 to $12.00 and set a "hold" rating on the stock in a research note on Friday, January 31st. Finally, Evercore ISI boosted their price target on Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock an "in-line" rating in a research report on Monday, January 13th. Four investment analysts have rated the stock with a sell rating, seven have given a hold rating and two have issued a buy rating to the company's stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus target price of $10.59.

Walgreens Boots Alliance Stock Down 0.2 %

NASDAQ WBA opened at $11.01 on Friday. The firm has a 50-day simple moving average of $10.95 and a 200 day simple moving average of $10.21. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.30 and a current ratio of 0.64. The stock has a market cap of $9.52 billion, a PE ratio of -1.08, a PEG ratio of 1.31 and a beta of 0.67. Walgreens Boots Alliance, Inc. has a twelve month low of $8.08 and a twelve month high of $18.83.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last announced its earnings results on Tuesday, April 8th. The pharmacy operator reported $0.63 EPS for the quarter, topping the consensus estimate of $0.53 by $0.10. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The business had revenue of $38.59 billion for the quarter, compared to the consensus estimate of $37.90 billion. During the same period in the previous year, the business earned $1.20 EPS. Walgreens Boots Alliance's revenue was up 4.1% compared to the same quarter last year. On average, research analysts forecast that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current year.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.